Release Date: 10/10/22 08:32 Summary: PDS dated 7 October 2022 Price Sensitive: No Download Document 431.05KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%